Evidence map›Paper›PMID 24246567›Full record

ArticleMedical decision making : an international journal of the Society for Medical Decision Making2014

Knowledge, attitudes, and self-efficacy as predictors of preparedness for oncology clinical trials: a mediational model.

Sharon Manne, Deborah Kashy, Terrance Albrecht, Yu-Ning Wong, Anne Lederman Flamm, Al B Benson, Suzanne M Miller, Linda Fleisher, Joanne Buzaglo, Nancy Roach and 9 more

Abstract read
In one paragraph

Article in Medical decision making : an international journal of the Society for Medical Decision Making, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Journal of child health care : for professionals working with children in the hospital and community · 2022
    Trial
  3. Trial
  4. Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2016
    Trial
  5. Evaluation of an Interactive, Educational Website Developed for Adolescents to Learn About Pediatric Clinical Trials: DigiKnowIt News.Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners
    Trial
  6. Article
  7. Article
  8. Article
  9. Educating Hispanics About Clinical Trials and Biobanking.Journal of cancer education : the official journal of the American Association for Cancer Education · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Patient knowledge and information-seeking about personalized cancer therapy.International journal of medical informatics · 2016
    Article
  14. Financial Concerns About Participation in Clinical Trials Among Patients With Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2016
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Sharon ManneCancer Institute of New Jersey, New Brunswick, NJ, USA (SM).
Deborah KashyDepartment of Psychology, Michigan State University, East Lansing, MI, USA (DK)
Terrance AlbrechtKarmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA(TA)
Yu-Ning WongFox Chase Cancer Center, Philadelphia, PA, USA (Y-NW, SMM, LF, ER, DP, SR)
Anne Lederman FlammDepartment of Bioethics, Center for Ethics, Humanities & Spiritual Care, Cleveland Clinic, Cleveland, OH, USA (ALF)
Al B BensonRobert H.Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA (ABB)
Suzanne M MillerFox Chase Cancer Center, Philadelphia, PA, USA (Y-NW, SMM, LF, ER, DP, SR)
Linda FleisherFox Chase Cancer Center, Philadelphia, PA, USA (Y-NW, SMM, LF, ER, DP, SR)
Joanne BuzagloCancer Support Community, Washington, DC, USA (JB)
Nancy RoachColorectal Cancer Coalition, Alexandria, VA, USA (NR)
Michael KatzInternational Myeloma Foundation, North Hollywood, CA, USA (MK)
Eric RossFox Chase Cancer Center, Philadelphia, PA, USA (Y-NW, SMM, LF, ER, DP, SR)
Michael CollinsMedical College of Wisconsin, Milwaukee, WI, USA (MC)
David PooleFox Chase Cancer Center, Philadelphia, PA, USA (Y-NW, SMM, LF, ER, DP, SR)
Stephanie RaivitchFox Chase Cancer Center, Philadelphia, PA, USA (Y-NW, SMM, LF, ER, DP, SR)
Dawn M MillerCase Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA (DMM, NJM)
Tyler G KinzyUniversity Hospitals Seidman Cancer Center, Cleveland, OH, USA (TGK, TL)
Tasnuva LiuUniversity Hospitals Seidman Cancer Center, Cleveland, OH, USA (TGK, TL)
Neal J MeropolCase Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA (DMM, NJM)
Cancer Institute of Florida · USFox Chase Cancer Center · USMichigan State University · USWayne State University · USThe Barbara Ann Karmanos Cancer Institute · USRutgers Cancer Institute of New Jersey

Funding

Preparatory Aid to Improve Decision Making about Cancer Clinical TrialsR01CA127655 · NCI · FOX CHASE CANCER CENTER · PI MEROPOL, NEAL J. · 2008 to 2013
$2.8M
NCI NIH HHS R01 CA127655
6 · The paper itself

Abstract

objectiveThis study used the Ottawa Decision Support Framework to evaluate a model examining associations between clinical trial knowledge, attitudinal barriers to participating in clinical trials, clinical trial self-efficacy, and clinical trial preparedness among 1256 cancer patients seen for their first outpatient consultation at a cancer center. As an exploratory aim, moderator effects for gender, race/ethnicity, education, and metastatic status on associations in the model were evaluated.

methods. Patients completed measures of cancer clinical trial knowledge, attitudinal barriers, self-efficacy, and preparedness. Structural equation modeling (SEM) was conducted to evaluate whether self-efficacy mediated the association between knowledge and barriers with preparedness.

results. The SEM explained 26% of the variance in cancer clinical trial preparedness. Self-efficacy mediated the associations between attitudinal barriers and preparedness, but self-efficacy did not mediate the knowledge-preparedness relationship.

conclusions. Findings partially support the Ottawa Decision Support Framework and suggest that assessing patients' level of self-efficacy may be just as important as evaluating their knowledge and attitudes about cancer clinical trials.

Indexed as

Health Knowledge, Attitudes, PracticeSelf EfficacyAgedAge FactorsClinical Trials as TopicFemaleHumansMaleMiddle AgedNeoplasmsResearch SubjectsSex Factorscancer clinical trialscancer patientsOttawa Decision Support Framework

Identifiers

PMID24246567
PMCPMC3991731
OpenAlexW2146006549

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.